Kai Hogrefe, MD

Original Contribution

Eptifibatide-Eluting Stent as an Antiproliferative and Antithrombotic Agent: In Vitro Evaluation

08/01/2008

Anthony H. Gershlick , MD, FRCP, MB, BS , BSc;

Coronary stent placement is the most commonly employed technique for percutaneous treatment of atherosclerotic heart disease. It accounts for about 75% of the procedures performed worldwide.1 In comparison to conventional balloon angioplasty,...

Coronary stent placement is the...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

See Full Calendar

Kai Hogrefe, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products